26th July 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

CDSCO Panel gives Intas Pharma go-ahead to study human normal immunoglobulin

The Phase III Clinical Trial of immunizing agent Human Normal Immunoglobulin for Intravenous Administration IP/EP, 5% and 10% Solution has been approved by the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization (CDSCO).

Punjab: 7.93L of pharma opioids seized in barely 7 days

Over 7.93 lakh pharma opioid tablets, capsules, and injections have been found by Punjab Police in the last week. 6.82 lakh intoxicating tablets, 17169 narcotic injectables, 85442 intoxicating capsules, and 8648 vials of intoxicating syrup were discovered.

Breckenridge Pharmaceutical receives USFDA approval for cancer treatment drug

US Food and Drug Administration has given Breckenridge Pharmaceutical, a Natco Pharma partner, approval for an abbreviated new drug application for the injectable powder form of capazitide, 60 mg/1.5 ml (40 mg/ml).

USFDA grants Lupin approval for their hypertension medication

US FDA has given Lupin permission to market its 40 mg and 80 mg Azilsartan Medoxomil tablets under an Abbreviated New Drug Application (ANDA). The main purpose of the medication is to lower high blood pressure.

SEC recommends approving ruxolitinib from Novartis for further purposes

Subject Expert Committee, which advises the drug regulator on the approval of oncology and hematology drugs, has advised granting Novartis Healthcare’s ruxolitinib tablets permission for an additional indication in patients 12 years of age and older.

Pharma companies advocate for 'One Molecule, One MRP' approach

Small and medium pharma company representatives have recommended that the government use a “one molecule-one MRP” formula rather than trade margin rationalization (TMR) for non-scheduled medications to lower their costs.

Indian Medical Associations urge WHO to classify monkeypox as sexually transmitted disease

The Indian Medical Associations have urged the United Nations agency for global public health to designate the virus as a sexually transmitted infection (STI) because 100% of cases are currently transmitted sexually. 

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?